IRIS Accounts Production v25.4.0.155 11798537 Board of Directors 1.4.24 31.3.25 31.3.25 false true false false true false Ordinary 1.00000 819 281 271 819 819 281 271 819 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh117985372024-03-31117985372025-03-31117985372024-04-012025-03-31117985372023-03-31117985372023-04-012024-03-31117985372024-03-3111798537ns15:EnglandWales2024-04-012025-03-3111798537ns14:PoundSterling2024-04-012025-03-3111798537ns10:Director12024-04-012025-03-3111798537ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3111798537ns10:SmallEntities2024-04-012025-03-3111798537ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3111798537ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3111798537ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3111798537ns10:FullAccounts2024-04-012025-03-3111798537ns10:OrdinaryShareClass12024-04-012025-03-311179853742ns10:Director22024-03-311179853742ns10:Director22023-03-311179853742ns10:Director22024-04-012025-03-311179853742ns10:Director22023-04-012024-03-311179853742ns10:Director22025-03-311179853742ns10:Director22024-03-3111798537ns10:Director22024-04-012025-03-3111798537ns10:RegisteredOffice2024-04-012025-03-3111798537ns5:CurrentFinancialInstruments2025-03-3111798537ns5:CurrentFinancialInstruments2024-03-3111798537ns5:ShareCapital2025-03-3111798537ns5:ShareCapital2024-03-3111798537ns5:RetainedEarningsAccumulatedLosses2025-03-3111798537ns5:RetainedEarningsAccumulatedLosses2024-03-3111798537ns5:FurnitureFittings2024-04-012025-03-3111798537ns5:MotorVehicles2024-04-012025-03-3111798537ns5:ComputerEquipment2024-04-012025-03-3111798537ns5:FurnitureFittings2024-03-3111798537ns5:MotorVehicles2024-03-3111798537ns5:ComputerEquipment2024-03-3111798537ns5:FurnitureFittings2025-03-3111798537ns5:MotorVehicles2025-03-3111798537ns5:ComputerEquipment2025-03-3111798537ns5:FurnitureFittings2024-03-3111798537ns5:MotorVehicles2024-03-3111798537ns5:ComputerEquipment2024-03-3111798537ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3111798537ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3111798537ns5:AcceleratedTaxDepreciationDeferredTax2025-03-3111798537ns5:AcceleratedTaxDepreciationDeferredTax2024-03-3111798537ns5:DeferredTaxation2024-03-3111798537ns5:DeferredTaxation2024-04-012025-03-3111798537ns5:DeferredTaxation2025-03-3111798537ns10:OrdinaryShareClass12025-03-3111798537ns10:Director112024-03-3111798537ns10:Director112023-03-3111798537ns10:Director112024-04-012025-03-3111798537ns10:Director112023-04-012024-03-3111798537ns10:Director112025-03-3111798537ns10:Director112024-03-31
REGISTERED NUMBER: 11798537 (England and Wales)











Unaudited Financial Statements

for the Year Ended 31 March 2025

for

Dr R J Lloyd Limited

Dr R J Lloyd Limited (Registered number: 11798537)






Contents of the Financial Statements
for the Year Ended 31 March 2025




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


Dr R J Lloyd Limited

Company Information
for the Year Ended 31 March 2025







DIRECTORS: Dr R J Lloyd
Dr S K Evans





REGISTERED OFFICE: Broadway House
19 High Street
Debenham
Stowmarket
Suffolk
IP14 6QL





REGISTERED NUMBER: 11798537 (England and Wales)





ACCOUNTANTS: Knights Lowe Ltd
Chartered Accountants
Crane Court
302 London Road
Ipswich
Suffolk
IP2 0AJ

Dr R J Lloyd Limited (Registered number: 11798537)

Statement of Financial Position
31 March 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 27,568 37,627

CURRENT ASSETS
Debtors 5 5,978 905
Cash at bank 105,439 61,763
111,417 62,668
CREDITORS
Amounts falling due within one year 6 10,626 1,356
NET CURRENT ASSETS 100,791 61,312
TOTAL ASSETS LESS CURRENT LIABILITIES 128,359 98,939

PROVISIONS FOR LIABILITIES 7 6,892 7,149
NET ASSETS 121,467 91,790

CAPITAL AND RESERVES
Called up share capital 8 100 100
Retained earnings 121,367 91,690
SHAREHOLDERS' FUNDS 121,467 91,790

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Dr R J Lloyd Limited (Registered number: 11798537)

Statement of Financial Position - continued
31 March 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 22 December 2025 and were signed on its behalf by:





Dr R J Lloyd - Director


Dr R J Lloyd Limited (Registered number: 11798537)

Notes to the Financial Statements
for the Year Ended 31 March 2025

1. STATUTORY INFORMATION

Dr R J Lloyd Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover from services provided by the company is measured at the fair value of the consideration received or receivable. When the outcome of a transaction can be estimated reliably, turnover from anaesthetic services is recognised by reference to the stage of completion at the statement of financial position date. Stage of completion is measured by reference to the date the service is provided.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on reducing balance
Motor vehicles - 25% on reducing balance
Computer equipment - 33% on cost

Financial instruments
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable and loans with related parties.

Debt instruments that are payable or receivable within one year, such as trade payables or receivables, are measured at the undiscounted amount of the cash or other consideration expected to be paid or received. Debt instruments that are repayable or receivable after one year are initially measured at the present value of the future cash flows and subsequently at amortised cost using the effective interest method.

Financial assets that are measured at cost and amortised cost are assessed at the end of each financial year for evidence of impairment. If objective evidence of impairment is found an impairment loss is recognised in the Income Statement.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.


Dr R J Lloyd Limited (Registered number: 11798537)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2024 - 3 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
and Motor Computer
fittings vehicles equipment Totals
£    £    £    £   
COST
At 1 April 2024 1,530 58,590 9,747 69,867
Additions - - 514 514
At 31 March 2025 1,530 58,590 10,261 70,381
DEPRECIATION
At 1 April 2024 735 25,634 5,871 32,240
Charge for year 199 8,239 2,135 10,573
At 31 March 2025 934 33,873 8,006 42,813
NET BOOK VALUE
At 31 March 2025 596 24,717 2,255 27,568
At 31 March 2024 795 32,956 3,876 37,627

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 4,987 86
Other debtors 991 819
5,978 905

Dr R J Lloyd Limited (Registered number: 11798537)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Taxation and social security 9,306 -
Other creditors 1,320 1,356
10,626 1,356

7. PROVISIONS FOR LIABILITIES
2025 2024
£    £   
Deferred tax
Accelerated capital allowances 6,892 7,149

Deferred
tax
£   
Balance at 1 April 2024 7,149
Credit to Statement of Income and Retained Earnings during year (257 )
Balance at 31 March 2025 6,892

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
100 Ordinary £1 100 100

9. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 March 2025 and 31 March 2024:

2025 2024
£    £   
Dr R J Lloyd and Dr S K Evans
Balance outstanding at start of year 819 281
Amounts advanced 271 819
Amounts repaid (819 ) (281 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 271 819

The loan was repaid in December 2025.